businesspress24.com - Coldstream Laboratories Expands Business Development Group
 

Coldstream Laboratories Expands Business Development Group

ID: 1264416

Pamela Savoy Added as Director of Business Development at Coldstream Laboratories, Inc.

(firmenpresse) - LEXINGTON, KY -- (Marketwired) -- 09/17/13 -- Laboratories, Inc., a provider of and sterile drug product development services, has announced that Pamela Savoy has joined the company as Director of Business Development. In this position, Ms. Savoy will be based out of Cleveland, OH, and will join Dr. Christopher Verbicky, Director of Business Development and Marketing, to expand Coldstream's business development group.

Ms. Savoy brings to Coldstream over 20 years of experience in the pharmaceutical industry, with particular expertise in the manufacturing of sterile liquid and lyophilized injectable products. Most recently, she's held positions at DS InPharmatics, Ben Venue Laboratories, and Roche Vitamins and Fine Chemicals. Ms. Savoy holds a bachelor of science degree in nutritional sciences from Rutgers University and a masters from Case Western Reserve University.

"We are pleased to announce the addition of Ms. Savoy to Coldstream's business development team," said Coldstream President and CEO Eric Smart. "Her experience and energy make her a perfect addition to our team and will provide Coldstream's prospective clients with a wealth of knowledge specific to the development and manufacture of parenteral drugs."

Coldstream Laboratories, Inc., based in Lexington, KY, is a privately held specialty pharmaceutical contract manufacturing organization. Coldstream operates Kentucky's only parenteral manufacturing facility.

For more information, visit or email .





Contact:
Kathy Sue Bennett
Tel: 859.977.8540
Email:




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Bio-Matrix Scientific Group Recruits RNA Interference Pioneer Dr. David Suhy to Regen BioPharma Inc.'s Scientific Advisor Board
BARDA Exercises $6.0MM in Additional Contract Funding for Development of AEOL-10150 as Treatment for Acute Radiation Syndrome
Bereitgestellt von Benutzer: Marketwired
Datum: 17.09.2013 - 09:02 Uhr
Sprache: Deutsch
News-ID 1264416
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

LEXINGTON, KY


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 127 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Coldstream Laboratories Expands Business Development Group
"
steht unter der journalistisch-redaktionellen Verantwortung von

Coldstream Laboratories (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Coldstream Laboratories



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 99


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.